Connect Sign In
Cancer Antigen-GI (CA 19-9), Body Fluid
Ordering Recommendation
Refer to aruplab.com/bodyfluids for clinical indications and interpretive information.
New York DOH Approval Status
Specimen Required
Biliary/Hepatic, CSF, Pancreatic, Peritoneal/Ascites, or Pleural fluid.
Centrifuge to remove cellular material. Transfer 1 mL body fluid to an ARUP Standard Transport Tube. (Min: 0.5 mL)
Refrigerated.
Specimen types other than those listed. Specimens too viscous to be aspirated by instrument.
Specimen source must be provided.
Ambient: 8 hours; Refrigerated: 5 days; Frozen: 3 months
Methodology
Quantitative Electrochemiluminescent Immunoassay
Performed
Sun-Sat
Reported
Within 24 hours
Reference Interval
Interpretive Data
The Roche CA 19-9 electrochemiluminescent immunoassay is used. Results obtained with different test methods or kits cannot be used interchangeably. The CA 19-9 value, regardless of level, should not be interpreted as absolute evidence of the presence or absence of malignant disease.
For information on body fluid reference ranges and/or interpretive guidance visit https://aruplab.com/bodyfluids/
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Laboratory Developed Test (LDT)
Note
Hotline History
CPT Codes
86301
Components
| Component Test Code* | Component Chart Name | LOINC |
|---|---|---|
| 0020747 | Cancer Antigen GI (CA 19-9), Body Fluid | 26924-1 |
| 2013040 | Cancer Antigen-GI(CA19-9) Fluid Source | 31208-2 |
Aliases
- CA 19-9 body fluid
- CA19-9 Abdominal Fluid
- CA19-9 Ascites Fluid
- CA19-9 Paracentesis Fluid
